BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18239069)

  • 1. Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.
    Pew T; Zou M; Brickley DR; Conzen SD
    Endocrinology; 2008 May; 149(5):2637-45. PubMed ID: 18239069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
    Wu W; Zou M; Brickley DR; Pew T; Conzen SD
    Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W; Pew T; Zou M; Pang D; Conzen SD
    J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.
    Wu W; Chaudhuri S; Brickley DR; Pang D; Karrison T; Conzen SD
    Cancer Res; 2004 Mar; 64(5):1757-64. PubMed ID: 14996737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes.
    Yuan SY; Liu J; Zhou J; Lu W; Zhou HY; Long LH; Hu ZL; Ni L; Wang Y; Chen JG; Wang F
    PLoS One; 2016; 11(8):e0159513. PubMed ID: 27513844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Lee HY; Chung JW; Youn SW; Kim JY; Park KW; Koo BK; Oh BH; Park YB; Chaqour B; Walsh K; Kim HS
    Circ Res; 2007 Feb; 100(3):372-80. PubMed ID: 17234971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop.
    Lützner N; Kalbacher H; Krones-Herzig A; Rösl F
    PLoS One; 2012; 7(7):e42166. PubMed ID: 22848740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo S; Sonenshein GE
    Mol Cell Biol; 2004 Oct; 24(19):8681-90. PubMed ID: 15367686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a.
    Li G; Lee YF; Liu S; Cai Y; Xie S; Liu NC; Bao BY; Chen Z; Chang C
    Endocrinology; 2008 Jul; 149(7):3490-9. PubMed ID: 18388194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
    Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
    Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
    McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
    Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
    Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
    J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Karadedou CT; Gomes AR; Chen J; Petkovic M; Ho KK; Zwolinska AK; Feltes A; Wong SY; Chan KY; Cheung YN; Tsang JW; Brosens JJ; Khoo US; Lam EW
    Oncogene; 2012 Apr; 31(14):1845-58. PubMed ID: 21860419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
    J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes.
    Reichardt SD; Föller M; Rexhepaj R; Pathare G; Minnich K; Tuckermann JP; Lang F; Reichardt HM
    Endocrinology; 2012 Apr; 153(4):1783-94. PubMed ID: 22294744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.